SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hyo-Jung Kwon, Young-Suk Won, Ogyi Park, Binxia Chang, Michael J. Duryee, Geoffrey E. Thiele, Akiko Matsumoto, Surendra Singh, Mohamed A. Abdelmegeed, Byoung-Joon Song, Toshihiro Kawamoto, Vasilis Vasiliou, Geoffrey M. Thiele, Bin Gao, Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice, Hepatology, 2014, 60, 1
  2. 2
    Elena Arriazu, Marina Ruiz de Galarreta, Francisco Javier Cubero, Marta Varela-Rey, María Pilar Pérez de Obanos, Tung Ming Leung, Aritz Lopategi, Aitor Benedicto, Ioana Abraham-Enachescu, Natalia Nieto, Extracellular Matrix and Liver Disease, Antioxidants & Redox Signaling, 2014, 21, 7, 1078

    CrossRef

  3. 3
    Sutapa Ray, Yingxin Zhao, Mohammad Jamaluddin, Chukwudi B. Edeh, Chang Lee, Allan R. Brasier, Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis, Cellular Signalling, 2014, 26, 7, 1445

    CrossRef

  4. 4
    Olav A. Gressner, Chunfang Gao, Monitoring fibrogenic progression in the liver, Clinica Chimica Acta, 2014, 433, 111

    CrossRef

  5. 5
    Rodrigo Feliciano do Carmo, Luydson Richardson Silva Vasconcelos, Taciana Furtado Mendonça, Maria do Socorro de Mendonça Cavalcanti, Leila Maria Moreira Beltrão Pereira, Patrícia Moura, Myeloperoxidase gene polymorphism predicts fibrosis severity in women with hepatitis C, Human Immunology, 2014, 75, 8, 766

    CrossRef

  6. 6
    Xiaodong Ge, Tung-Ming Leung, Elena Arriazu, Yongke Lu, Raquel Urtasun, Brian Christensen, Maria Isabel Fiel, Satoshi Mochida, Esben S. Sørensen, Natalia Nieto, Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice, Hepatology, 2014, 59, 4
  7. 7
    Simona Clichici, Diana Olteanu, Andras-Laszlo Nagy, Adrian Oros, Adriana Filip, Petru A. Mircea, Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats, Journal of Medicinal Food, 2014, 140818132015003

    CrossRef

  8. You have free access to this content8
    Alain Beschin, Patrick De Baetselier, Jo A Van Ginderachter, Contribution of myeloid cell subsets to liver fibrosis in parasite infection, The Journal of Pathology, 2013, 229, 2
  9. 9
    Jinhwa Lee, Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma, The Korean Journal of Physiology & Pharmacology, 2013, 17, 5, 375

    CrossRef

  10. 10
    Dong-Su Shin, Kung Wook Kim, Hae Young Chung, Sik Yoon, Jeon-Ok Moon, Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats, Archives of Pharmacal Research, 2013, 36, 5, 608

    CrossRef

  11. 11
    Kewei Wang, Bingliang Lin, John J. Brems, Richard L. Gamelli, Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway, Apoptosis, 2013, 18, 5, 566

    CrossRef

  12. 12
    Jean-Philippe Pradere, Johannes Kluwe, Samuele Minicis, Jing-Jing Jiao, Geum-Youn Gwak, Dianne H. Dapito, Myoung-Kuk Jang, Nina D. Guenther, Ingmar Mederacke, Richard Friedman, Ana-Cristina Dragomir, Costica Aloman, Robert F. Schwabe, Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice, Hepatology, 2013, 58, 4
  13. 13
    Er-Bao Bian, Bing Zhao, Cheng Huang, Hua Wang, Xiao-Ming Meng, Bao-Ming Wu, Tao-Tao Ma, Lei Zhang, Xiong-Wen Lv, Jun Li, New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery, Cellular Signalling, 2013, 25, 9, 1837

    CrossRef

  14. 14
    Sanjaya Kumar Satapathy, Satheesh Nair, Jason M. Vanatta, Nonalcoholic fatty liver disease following liver transplantation, Hepatology International, 2013, 7, 2, 400

    CrossRef

  15. 15
    Tung-Ming Leung, Xiaodong Wang, Naoto Kitamura, Maria I Fiel, Natalia Nieto, Osteopontin delays resolution of liver fibrosis, Laboratory Investigation, 2013, 93, 10, 1082

    CrossRef

  16. 16
    B. Sid, J. Verrax, P. B. Calderon, Role of oxidative stress in the pathogenesis of alcohol-induced liver disease, Free Radical Research, 2013, 47, 11, 894

    CrossRef

  17. 17
    Qiao Yang, Yanning Liu, Yu Shi, Min Zheng, Jiliang He, Zhi Chen, The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure, Immunobiology, 2013, 218, 10, 1284

    CrossRef

  18. 18
    Jakob Harslund, Dorte Frees, Páll S. Leifsson, Hanne Offenberg, Maria U. Rømer, Nils Brünner, John E. Olsen, The role of Serpine-1 and Tissue inhibitor of metalloproteinase type-1 in early host responses to Staphylococcus aureus intracutaneous infection of mice, Pathogens and Disease, 2013, 68, 3
  19. 19
    Natalia Nieto, A systems biology approach for understanding the collagen regulatory network in alcoholic liver disease, Liver International, 2012, 32, 2
  20. 20
    Elisabetta Mormone, Yongke Lu, Xiaodong Ge, Maria Isabel Fiel, Natalia Nieto, Fibromodulin, an Oxidative Stress-Sensitive Proteoglycan, Regulates the Fibrogenic Response to Liver Injury in Mice, Gastroenterology, 2012, 142, 3, 612

    CrossRef

  21. 21
    Hai Li, Huan-Wei Zheng, Hui Chen, Zhi-Zhi Xing, Hong You, Min Cong, Ji-Dong Jia, Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-β1 over pro-inflammatory cytokines, Digestive and Liver Disease, 2012, 44, 4, 328

    CrossRef

  22. 22
    Cheng Liu, Gaoqiang Wang, Gaofeng Chen, Yongping Mu, Lijun Zhang, Xudong Hu, Mingyu Sun, Chenghai Liu, Ping Liu, Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis, BMC Complementary and Alternative Medicine, 2012, 12, 1, 51

    CrossRef

  23. 23
    P. E. Pardee, W. Dunn, J. B. Schwimmer, Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children, Alimentary Pharmacology & Therapeutics, 2012, 35, 2
  24. 24
    Aleksandar Sokolović, Paula S. Montenegro-Miranda, Dirk Rudi de Waart, Radha M.N. Cappai, Suzanne Duijst, Milka Sokolović, Piter J. Bosma, Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012, 1822, 6, 996

    CrossRef

  25. 25
    Zixue Jin, Rui Sun, Haiming Wei, Xiang Gao, Yongyan Chen, Zhigang Tian, Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells, Hepatology, 2011, 53, 1
  26. 26
    Natalia Nieto, Matthias P. Lutolf, Extracellular matrix bioengineering and systems biology approaches in liver disease, Systems and Synthetic Biology, 2011, 5, 1-2, 11

    CrossRef

  27. 27
    Yu-Ting Lo, Ya-Hui Tsai, Shu-Ju Wu, Jiun-Rong Chen, Jane C.-J. Chao, Ginsenoside Rb1 Inhibits Cell Activation and Liver Fibrosis in Rat Hepatic Stellate Cells, Journal of Medicinal Food, 2011, 14, 10, 1135

    CrossRef

  28. 28
    Christian Schachtrup, Natacha Le Moan, Melissa A. Passino, Katerina Akassoglou, Hepatic stellate cells and astrocytes, Cell Cycle, 2011, 10, 11, 1764

    CrossRef

  29. 29
    Rong Wang, Yue Nan, Wen Wu, Ling Kong, Fang Han, Su Zhao, Li Kong, Jun Yu, Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice, Lipids in Health and Disease, 2011, 10, 1, 31

    CrossRef

  30. 30
    Yingdi Liu, Joanne Brymora, Hongyi Zhang, Briohny Smith, Mehdi Ramezani–Moghadam, Jacob George, Jianhua Wang, Leptin and Acetaldehyde Synergistically Promotes αSMA Expression in Hepatic Stellate Cells by an Interleukin 6-Dependent Mechanism, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  31. 31
    Elisabetta Mormone, Joseph George, Natalia Nieto, Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches, Chemico-Biological Interactions, 2011, 193, 3, 225

    CrossRef

  32. 32
    Simona Clichici, C. Catoi, T. Mocan, A. Filip, C. Login, A. Nagy, D. Daicoviciu, N. Decea, C. Gherman, R. Moldovan, Adriana Muresan, Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis, Acta Physiologica Hungarica, 2011, 98, 2, 195

    CrossRef

  33. 33
    Roberto Gambino, Giovanni Musso, Maurizio Cassader, Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities, Antioxidants & Redox Signaling, 2011, 15, 5, 1325

    CrossRef

  34. 34
    Hua Wang, Fouad Lafdil, Lei Wang, Shi Yin, Dechun Feng, Bin Gao, Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production, Cell & Bioscience, 2011, 1, 1, 14

    CrossRef

  35. 35
    Sayaka Inokuchi, Hidekazu Tsukamoto, EekJoong Park, Zhang-Xu Liu, David A. Brenner, Ekihiro Seki, Toll-Like Receptor 4 Mediates Alcohol-Induced Steatohepatitis Through Bone Marrow-Derived and Endogenous Liver Cells in Mice, Alcoholism: Clinical and Experimental Research, 2011, 35, 8
  36. 36
    Eduardo L.M. Guimarães, Christophe Empsen, Albert Geerts, Leo A. van Grunsven, Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells, Journal of Hepatology, 2010, 52, 3, 389

    CrossRef

  37. 37
    Luís Otávio Miranda Cota, Michelle Beatriz Viana, Paula Rocha Moreira, Ricardo Santiago Gomez, José Roberto Cortelli, Sheila Cavalca Cortelli, Fernando Oliveira Costa, Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (−174 G/C) gene polymorphism, Archives of Oral Biology, 2010, 55, 7, 494

    CrossRef

  38. 38
    Cheng Liu, Qing Tao, Mingyu Sun, Jim Z Wu, Wengang Yang, Ping Jian, Jinghua Peng, Yiyang Hu, Chenghai Liu, Ping Liu, Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats, Laboratory Investigation, 2010, 90, 12, 1805

    CrossRef

  39. 39
    G. Musso, R. Gambino, M. Cassader, Non-alcoholic fatty liver disease from pathogenesis to management: an update, Obesity Reviews, 2010, 11, 6
  40. 40
    Sarah M. Lindbäck, Charles Gabbert, Benjamin L. Johnson, Emmanuil Smorodinsky, Claude B. Sirlin, Natalie Garcia, Perrie E. Pardee, Kristin D. Kistler, Jeffrey B. Schwimmer, Pediatric Nonalcoholic Fatty Liver Disease: A Comprehensive Review, Advances in Pediatrics, 2010, 57, 1, 85

    CrossRef

  41. 41
    Cheng Huang, Taotao Ma, Xiaoming Meng, Xiongwen Lv, Lei Zhang, Jianqing Wang, Jun Li, Potential protective effects of a traditional Chinese herb, Litsea coreana Levl., on liver fibrosis in rats, Journal of Pharmacy and Pharmacology, 2010, 62, 2
  42. 42
    Matthias Zenkel, Piotr Lewczuk, Anselm Jünemann, Friedrich E. Kruse, Gottfried O.H. Naumann, Ursula Schlötzer-Schrehardt, Proinflammatory Cytokines Are Involved in the Initiation of the Abnormal Matrix Process in Pseudoexfoliation Syndrome/Glaucoma, The American Journal of Pathology, 2010, 176, 6, 2868

    CrossRef

  43. 43
    Yuzo Kodama, Tatiana Kisseleva, Keiko Iwaisako, Kouichi Miura, Kojiro Taura, Samuele De Minicis, Christoph H. Österreicher, Bernd Schnabl, Ekihiro Seki, David A. Brenner, c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice, Gastroenterology, 2009, 137, 4, 1467

    CrossRef

  44. 44
    Jianhua Wang, Isabelle Leclercq, Joanne M. Brymora, Ning Xu, Mehdi Ramezani–Moghadam, Roslyn M. London, David Brigstock, Jacob George, Kupffer Cells Mediate Leptin-Induced Liver Fibrosis, Gastroenterology, 2009, 137, 2, 713

    CrossRef

  45. 45
    Fabio Marra, Sara Aleffi, Sara Galastri, Angela Provenzano, Mononuclear cells in liver fibrosis, Seminars in Immunopathology, 2009, 31, 3, 345

    CrossRef

  46. 46
    S. Petta, C. Muratore, A. Craxì, Non-alcoholic fatty liver disease pathogenesis: The present and the future, Digestive and Liver Disease, 2009, 41, 9, 615

    CrossRef

  47. 47
    Kyoko Toda, Naoki Kumagai, Fumihiko Kaneko, Satoshi Tsunematsu, Kanji Tsuchimoto, Hidetsugu Saito, Toshifumi Hibi, Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production, Journal of Gastroenterology and Hepatology, 2009, 24, 5
  48. 48
    Raquel Urtasun, Francisco Javier Cubero, María Vera, Natalia Nieto, Reactive Nitrogen Species Switch on Early Extracellular Matrix Remodeling via Induction of MMP1 and TNFα, Gastroenterology, 2009, 136, 4, 1410

    CrossRef

  49. 49
    Olav A Gressner, Mohamed S Rizk, Evgeniya Kovalenko, Ralf Weiskirchen, Axel M Gressner, Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?, Journal of Gastroenterology and Hepatology, 2008, 23, 7pt1
  50. 50
    Christine Carter-Kent, Nizar N. Zein, Ariel E. Feldstein, Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment, The American Journal of Gastroenterology, 2008, 103, 4, 1036

    CrossRef

  51. 51
    Francisco Javier Cubero, Natalia Nieto, Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor α, reduced glutathione, and transforming growth factor β–dependent mechanisms, Hepatology, 2008, 48, 6
  52. 52
    Anna Wieckowska, Bettina G. Papouchado, ZhengZheng Li, Rocio Lopez, Nizar N. Zein, Ariel E. Feldstein, Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis, The American Journal of Gastroenterology, 2008, 103, 6, 1372

    CrossRef

  53. 53
    Won-Il Jeong, Bin Gao, Innate immunity and alcoholic liver fibrosis, Journal of Gastroenterology and Hepatology, 2008, 23,
  54. 54
    Maurizio Parola, Fabio Marra, Massimo Pinzani, Myofibroblast – like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario, Molecular Aspects of Medicine, 2008, 29, 1-2, 58

    CrossRef

  55. 55
    R. Urtasun, L. Conde de la Rosa, N. Nieto, Oxidative and Nitrosative Stress and Fibrogenic Response, Clinics in Liver Disease, 2008, 12, 4, 769

    CrossRef

  56. 56
    Maria J. Perugorria, M. Ujue Latasa, Alexandra Nicou, Hugo Cartagena-Lirola, Josefa Castillo, Saioa Goñi, Umberto Vespasiani-Gentilucci, Maria G. Zagami, Sophie Lotersztajn, Jesús Prieto, Carmen Berasain, Matias A. Avila, The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis, Hepatology, 2008, 48, 4
  57. 57
    Mohammad R. Ebrahimkhani, Ahmed M. Elsharkawy, Derek A. Mann, Wound healing and local neuroendocrine regulation in the injured liver, Expert Reviews in Molecular Medicine, 2008, 10,

    CrossRef

  58. 58
    George Bou-Gharios, Benoit de Crombrugghe, Principles of Bone Biology, 2008,

    CrossRef

  59. 59
    Scott J. Cotler, Eric Kallwitz, Veronica TenCate, Anita Bhushan, Jamie Berkes, Enrico Benedetti, Jennifer Layden-Almer, Thomas J. Layden, Tibor Valyi-Nagy, Grace Guzman, Diabetes and Hepatic Oxidative Damage Are Associated With Hepatitis C Progression After Liver Transplantation, Transplantation, 2007, 84, 5, 587

    CrossRef

  60. 60
    Natalia Nieto, Ethanol and fish oil induce NFκB transactivation of the collagen α2(I) promoter through lipid peroxidation–driven activation of the PKC-PI3K-Akt pathway, Hepatology, 2007, 45, 6
  61. 61
    Samuele De Minicis, Ekihiro Seki, Hiroshi Uchinami, Johannes Kluwe, Yonghui Zhang, David A. Brenner, Robert F. Schwabe, Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo, Gastroenterology, 2007, 132, 5, 1937

    CrossRef

  62. 62
    Integrated Global Systems Biology for the Research and Development of Chinese Medicine Shuanglong Formula,